Feature of primary GB carcinoma | N0 (Percentage) |
---|---|
Clinical symptoms (abdominal pain, jaundice, nausea and vomiting, weight loss) | 5/10 (50%) |
Mass | 8/10 (80%) |
Gallstones | 9/10 (90%) |
Mass associated with gallstones | 8/9 (89%) |
Pre-op diagnosis benign diseases | 5/10 (50%) |
Pre-op diagnosis GB cancer | 2/10 (20%) |
Pre-op diagnosis bile duct tumor | 3/10 (30%) |
Malignant postoperative diagnosis | Primary: 10/23 (43%) |
 | Metastasis to GB: 6/23 (26%) |
 | Bile duct carcinoma invasive into GB: 6/23 (26%) |
 | Unidentified origin carcinoma: 1/23 (5%) |